The Royalty Pharma Translational Prize honors scientists whose breakthroughs bridge the gap between fundamental discovery and the development of new medicines that improve and extend patients’ lives.

The prize recognizes translational contributions not yet celebrated by the field’s highest-profile awards.

Amount

$1 million distributed
among one or more
established scientists

Frequency

Annual

Scope

Broad translational
medicine focus in
any disease area

Geographic Scope

Global

Career Stage

Established scientists
with demonstrated
clinical impact

Orientation

Retrospective
recognition

Sir Gregory Paul Winter

Breakthroughs in science only realize their full value when they reach patients. The Royalty Pharma Translational Prize celebrates those who have the vision and persistence to carry ideas across that difficult but vital bridge.

The Royalty Pharma
Translational Prize recognizes and celebrates scientists whose fundamental discoveries have been successfully translated into medicines that meaningfully improve patients’ lives.

Pablo Legorreta

TIMELINE